Markets:

Overview

News

Currencies

International

Treasuries

Annovis Bio, Inc. Common Stock (NY:ANVS)

4.820 +0.730 (+17.85%)

Official Closing Price Updated: 7:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Annovis Bio, Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Mid-Day Market Update: LendingClub Surges Following Strong Q2 Results; Atreca Shares Plummet ↗

July 29, 2021

Midway through trading Thursday, the Dow traded up 0.55% to 35,122.75 while the NASDAQ rose 0.47% to 14,831.28. The S&P also rose, gaining 0.61% to 4,427.36. The U.S. has the...

Via Benzinga

Topics Stocks

44 Stocks Moving In Thursday's Mid-Day Session ↗

July 29, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Mastercard Profit Beats Estimates ↗

July 29, 2021

Following the market opening Thursday, the Dow traded up 0.44% to 35,085.92 while the NASDAQ rose 0.27% to 14,802.51. The S&P also rose, gaining 0.45% to 4,420.49. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Annovis Bio Stock Crashes After Much-Hyped Alzheimer's Drug Flops In Midstage Test ↗

July 29, 2021

Annovis Bio's Alzheimer's drug failed to significantly outperform the placebo in a midstage test, leading ANVS stock to plummet on Thursday.

Via Investor's Business Daily

28 Stocks Moving in Thursday's Pre-Market Session ↗

July 29, 2021

Gainers LendingClub Corporation (NYSE: LC) shares rose 44.6% to $23.49 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance. Acer...

Via Benzinga

Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch ↗

July 23, 2021

Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell.

Via Investor's Business Daily

Annovis Bio's Alzheimer's Candidate To Proceed Into Final Cohort Of Mid-Stage Study, Data Expected In 2022 ↗

July 20, 2021

Data Safety Monitoring Board (DSMB) has reviewed safety and tolerability data for Cohort 2 of Annovis Bio Inc's (NYSE: ANVS) Phase 2 Alzheimer's disease trial...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Got $2,500? Check Out These 3 Alzheimer's Therapy Stocks ↗

July 17, 2021

Treating Alzheimer's is extremely difficult, but these innovative companies are taking a stab at it.

Via The Motley Fool

Here's Why The Biotech Stocks You Bought Keep Going Down ↗

July 17, 2021

Good news! There's a way to avoid this portfolio pain -- and it doesn't involve avoiding the whole sector.

Via The Motley Fool

Better Biotech Stock: Biogen vs. Annovis Bio ↗

July 16, 2021

Both are making Alzheimer's drugs, but only one can claim success as of today.

Via The Motley Fool

58 Biggest Movers From Yesterday ↗

July 13, 2021

Gainers MediaCo Holding Inc. (NASDAQ: MDIA) shares jumped 311.6% to close at $17.00 on Monday after jumping 20% on Friday. State Auto Financial Corporation (NASDAQ: STFC) shares...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

July 12, 2021

Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in...

Via Benzinga

Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021 ↗

July 04, 2021

Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P...

Via Talk Markets

Topics Stocks

Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021 ↗

July 04, 2021

Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ...

Via Benzinga

Annovis Bio to Present Data at Alzheimer's Association International Conference 2021 Highlighting Positive Clinical Outcomes from Its Two Phase 2a Trials

July 02, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - July 2, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Annovis Bio CEO Wins 2021 PACT Enterprise Award for Life Sciences and Healthcare CEO

July 01, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - July 1, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Annovis Bio CEO Selected as a Finalist in the 2021 PACT Enterprise Awards

June 24, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - June 24, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

44 Biggest Movers From Yesterday ↗

June 23, 2021

Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

June 17, 2021

This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries...

Via Benzinga

These 2 Biotech Stocks Are Up 1,000% This Year ↗

June 16, 2021

New approaches to treating Alzheimer's could mean even bigger gains in the future.

Via The Motley Fool

64 Biggest Movers From Friday ↗

June 14, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...

Via Benzinga

Topics Initial Public Offering

Biotechs Ready To Roar ↗

June 13, 2021

The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...

Via Talk Markets

46 Stocks Moving In Friday's Mid-Day Session ↗

June 11, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...

Via Benzinga

Topics Initial Public Offering

Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments ↗

June 11, 2021

Data doesn't lie. These companies have the potential to quickly steal the spotlight.

Via The Motley Fool

Annovis Bio to Present at 2021 BIO Digital

June 10, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - June 10, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher ↗

June 10, 2021

With updates from clinical trials expected as soon as this month, anything is possible.

Via The Motley Fool

Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use? ↗

June 08, 2021

Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.

Via Investor's Business Daily

Annovis' Alzheimer's/Parkinson's Candidate Protects Nerve Cells Against Ill Effects of Higher Neurotoxic Proteins ↗

June 08, 2021

Annovis Bio Inc (NYSE: ANVS) has announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Annovis Bio, Inc. Common Stock (NY:ANVS)

All News about Annovis Bio, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today